Celltrion will supply DiaTrustTM COVID-19 Rapid Test, co-developed with Humasis, an in vitro diagnostic company, to the United States through Celltrion USA.

According to the company on the 23rd, Celltrion USA was finally selected as a supplier in a purchasing project conducted by DLA under the U.S. Department of Defense. As early as the 1st of next month, it will begin supplying DiaTrust to 25,000 designated procurement sites in the United States, including military facilities, nursing homes, regional inspection centers, and major facilities.

The contract period is until September 16 next year. The contract amount can increase by up to 738.2 billion won depending on the situation, the lar